Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

°£¼¼Æ÷¾ÏÁ¾ ȯÀÚ¿¡¼­ °æµ¿¸ÆÈ­ÇлöÀü¼ú ÈÄ ¹ß»ýÇÑ ´ã³¶ õ°ø 1¿¹ Gallbladder Perforation after Transarterial Chemoembolization in a Patient with a Huge Hepatocellular Carcinoma

´ëÇѼÒÈ­±âÇÐȸÁö 2020³â 75±Ç 6È£ p.351 ~ 355
¼Õ¹Î¿µ, ÇѺ´ÈÆ, ÀÌ»ó¿í, À±º´Ã¶, ¼­±¤ÀÏ, ÇãÁøµµ,
¼Ò¼Ó »ó¼¼Á¤º¸
¼Õ¹Î¿µ ( Son Min-Young ) 
Kosin University College of Medicine Department of Internal Medicine

ÇѺ´ÈÆ ( Han Byung-Hoon ) 
Kosin University College of Medicine Department of Internal Medicine
ÀÌ»ó¿í ( Lee Sang-Uk ) 
Kosin University College of Medicine Department of Internal Medicine
À±º´Ã¶ ( Yun Byung-Cheol ) 
Kosin University College of Medicine Department of Internal Medicine
¼­±¤ÀÏ ( Seo Kwang-Il ) 
Kosin University College of Medicine Department of Internal Medicine
ÇãÁøµµ ( Huh Jin-Do ) 
Kosin University College of Medicine Department of Radiology

Abstract


Transarterial chemoembolization (TACE) is a common treatment for unresectable hepatocellular carcinoma (HCC). The most common complications after TACE are non-specific symptoms called post-embolization syndrome, such as abdominal pain or fever. Rare complications, such as liver failure, liver abscess, sepsis, pulmonary embolism, cholecystitis, can also occur. On the other hand, gallbladder perforation is quite rare. This paper reports a case of gallbladder perforation following TACE. A 76-year-old male with a single 9-cm-sized HCC underwent TACE. Five days after TACE, he developed persistent right upper quadrant pain and ileus. An abdomen CT scan confirmed gallbladder perforation with bile in the right paracolic gutter and pelvic cavity. Percutaneous transhepatic gallbladder drainage was performed with the intravenous administration of antibiotics. After 1 month, the patient underwent right hemihepatectomy and cholecystectomy. Physicians should consider the possibility of gallbladder perforation, which is a rare complication after TACE, when unexplained abdominal pain persists.

Å°¿öµå

Gallbladder; Rupture; Chemoembolization, therapeutic; Carcinoma, hepatocellular

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

MEDLINE
KCI
KoreaMed
KAMS